Anebulo Pharmaceuticals
(OTC) ANEB
Anebulo Pharmaceuticals Financials at a Glance
Market Cap
$37.27M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.98M
EPS (TTM)
$-0.19
P/E Ratio
-4.71
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Price
$0.91
Volume
15,204
Open
$1.07
Price
$0.91
Volume
15,204
Open
$1.07
Previous Close
$0.91
Daily Range
$0.69 - $1.07
52-Week Range
$0.30 - $3.42
Dividend
$0.00
Beta (Volatility)
0.46 (Low)
Price
$0.91
Volume
15,204
Open
$1.07
Previous Close
$0.91
Daily Range
$0.69 - $1.07
52-Week Range
$0.30 - $3.42
ANEB News
ANEB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Anebulo Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
3
CEO
Richard Anthony Cunningham
Website
www.anebulo.comHeadquarters
Lakeway, TX 78734, US
ANEB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-70%
Return on Capital
-1%
Return on Assets
-85%
Earnings Yield
-21.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$37.27M
Shares Outstanding
40.78M
Volume
15.20K
Short Interest
0.00%
Avg. Volume
113.21K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.22M
EBITDA
$8.10M
Operating Cash Flow
$6.35M
Capital Expenditure
$3.00
Free Cash Flow
$6.35M
Cash & ST Invst.
$11.63M
Total Debt
$0.00
Anebulo Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$37.27M
N/A
Market Cap/Employee
$18.64M
N/A
Employees
2
N/A
Net Income
$2.00M
+18.8%
EBITDA
$2.62M
-9.0%
Quarterly Fundamentals
Net Cash
$9.04M
-39.7%
Accounts Receivable
$56.78K
+84.6%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-84.68%
N/A
Return on Invested Capital
-1.03%
N/A
Free Cash Flow
$1.31M
+6.6%
Operating Cash Flow
$1.31M
+6.6%